Safety profile of D-penicillamine: a comprehensive pharmacovigilance analysis by FDA adverse event reporting system-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety profile of D-penicillamine: a comprehensive pharmacovigilance analysis by FDA adverse event reporting system

Published:2021-07-26 Issue:11 Volume:20 Page:1443-1450
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Kumar Vijay¹^ORCID,Singh Anand Prakash²^ORCID,Wheeler Nicholas³,Galindo Cristi L.³,Kim Jong-Joo¹

Affiliation:

1. Department of Biotechnology, Yeungnam University, Gyeongsan, Republic of Korea

2. Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA

3. Department of Biology, Western Kentucky University, Bowling Green, KY, USA

Funder

commercial, or not-for-profit sectors

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2021.1956460

Reference62 articles.

1. Heavy metal toxicity: An update of chelating therapeutic strategies

2. Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing

3. Wilson disease

4. Update on the Diagnosis and Management of Wilson Disease

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Relationship between Seropositive Rheumatoid Arthritis and Congestive Heart Failure: A Nationwide Longitudinal Cohort Study in Korea;Journal of Personalized Medicine;2024-06-08

2. Characterization of renal damage in Wilson's disease—Detailed analysis of 20 Chinese cases;Medicina Clínica;2024-06

3. Roles and mechanisms of copper homeostasis and cuproptosis in osteoarticular diseases;Biomedicine & Pharmacotherapy;2024-05

4. Kidney involvement in Wilson's disease: a review of the literature;Clinical Kidney Journal;2024-03-09

5. Prevalence, Incidence, and Treatment Pattern of Wilson’s Disease Using National Health Insurance Data From 2010-2020, Korea;Journal of Korean Medical Science;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3